Published • loading... • Updated
Pharma industry urges EU capitals to act on Trump pricing squeeze
Summary by EURACTIV
3 Articles
3 Articles
In the US medicines cost up to 422% more: Trump blames the EU. What is really its goal and how it can cause a shortage of global supplies
·Italy
Read Full Article16:31 Pharmaceutical giants Merck, AstraZeneca, and Sanofi are cutting or pausing British investments, partly due to dissatisfaction with low drug prices. The same debate is heating up across Europe, fueled by...
·Belgium
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium